Sign in Request access
Sign inRequest access
Awarded

This opportunity has been awarded. Its page stays for reference.

Similar open opportunities

AwardedTender

Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und der hcd medical GmbH zu Vabysmo

At a glance

IKK classic is procuring Pharmaceutical products (CPV 33600000). It has been awarded. The notice states an estimated value of €1 excl. VAT. Procedure type: Negotiated without prior call for competition.

From the notice

Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und der hcd medical GmbH zu Vabysmo (Wirkstoff: Faricimab , ATC-Code: S01LA09), Vertragslaufzeit: 01.08.2026-31.07.2028

Key facts

Each fact is from the official notice, last checked 9 November 2026, 12:31 (UTC+01:00).

Status
AwardedOfficial notice · checked 9 Nov 2026, 12:31 (UTC+01:00)
Deadline
No deadline in the noticeOfficial notice · checked 9 Nov 2026, 12:31 (UTC+01:00)
Published value
€1 excl. VATOfficial notice · checked 9 Nov 2026, 12:31 (UTC+01:00)
Buyer
IKK classic, Dresden, DEOfficial notice · checked 9 Nov 2026, 12:31 (UTC+01:00)
Main CPV
Pharmaceutical products (CPV 33600000)Official notice · checked 9 Nov 2026, 12:31 (UTC+01:00)
Procedure
Negotiated without prior call for competitionOfficial notice · checked 9 Nov 2026, 12:31 (UTC+01:00)
Lots
1Official notice · checked 9 Nov 2026, 12:31 (UTC+01:00)
First published
5 August 2026, 11:07 (UTC+02:00)Official notice · checked 9 Nov 2026, 12:31 (UTC+01:00)

Fact sheet

Inteliwert fact sheet: Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und der hcd medical GmbH zu Vabysmo — IKK classic. A product of Bandpey GmbH.
The key facts of this page as an image (PNG, 1600 × 900), made from the official notice. © Bandpey GmbH; terms of use. Download the fact sheet

Lots (1)

  1. Lot LOT-0000: Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und der hcd medical GmbH zu Vabysmo

    Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und der hcd medical GmbH zu Vabysmo (Wirkstoff: Faricimab , ATC-Code: S01LA09), Vertragslaufzeit: 01.08.2026-31.07.2028

    CPV
    Pharmaceutical products (CPV 33600000)
    Published value
    €1 excl. VAT

Timeline

  1. Award: Award. Winner: hvd medical GmbH; Award value: €1 excl. VAT; Tenders received: 1; Lot LOT-0000.
  2. 5 August 2026, 11:07 (UTC+02:00): Award notice Notice, version 01 (Contract or concession award notice – standard regime). Official notice

Buyer and place

Buyer

IKK classic
Dresden, DE

Other parties in the notice

  • hvd medical GmbH (Tenderer), Saarlouis
  • hvd medical GmbH (Winner), Saarlouis

Classification

CPV codes

  • 33600000: Pharmaceutical products

Official documents

No documents found in the indexed notice.

Questions and answers

Who is the buyer?

IKK classic, Dresden, DE.

What is being procured (CPV)?

Pharmaceutical products (CPV 33600000).

What is the estimated value?

The notice states an estimated value of €1 excl. VAT.

Is it divided into lots?

No, the notice names a single lot.

Which procedure is used?

Negotiated without prior call for competition.

How do I submit a bid?

On the official notice or the portal it names. Inteliwert does not submit bids. Official notice

Am I eligible?

Inteliwert does not judge eligibility. The selection criteria are in the official notice. Official notice

More from this buyer

Other published opportunities of this buyer in the indexed notices, open ones first.

Source

Publisher
Bekanntmachungsservice
Licence
CC0 1.0
Last checked
9 November 2026, 12:31 (UTC+01:00)

The official notice is authoritative. Inteliwert shows what the notice states and links to it.

Markdown version